Dengue fever vaccine available in Indonesia or known as CYD-TDV (Dengvaxia) has been approved by Drug and Food Monitoring (BPOM) Indonesia.
Dengue fever is a disease caused by dengue virus infection transmitted through the bite of female Aedes aegypti mosquito. Dengue fever usually occurs during rainy season. This is because high rainfall allows mosquitoes to breed especially in tropical areas including Indonesia. Dengue fever vaccine available in Indonesia is Dengvaxia as it was introduced in 2016. However, the prevention of dengue fever can be handled by getting dengue fever vaccine. It functions to prevent as well as a drug to stop the dengue virus in the body.
Dengue Fever Vaccine Available in Indonesia
Dengue fever vaccine is intended to prevent dengue in endemic areas due to dengue virus infection. Dengue fever vaccine available in Indonesia is the CYD-TDV (Dengvaxia) vaccine. It has first been given the green light by the Drug and Food Monitoring (BPOM) Indonesia. This vaccine contains a weakened tetravalent dengue virus. The vaccine forms immunity against four types of circulating dengue viruses; dengue virus serotype 1-4.
However, not everyone is allowed to get dengue fever vaccine available in Indonesia. Followings are the conditions that is forbidden to get this vaccine:
- Pregnant and nursing mothers.
- Having a history of severe allergic reactions to the contents of the dengue fever vaccine or other vaccines with the same content.
- Experiencing moderate or severe fever.
- Patients with HIV infection both symptomatic (with symptoms) and asymptomatic (without symptoms).
Additionally, before you decide to get dengue fever vaccine, consult a doctor first. Tell your doctor about your medical history to ensure that you are suitable to receive the vaccine. You can consult a doctor at Medi-Call and get dengue fever vaccine available in Indonesia to your location through Medi-Call application or simply contact Medi-Call hotline at +62 81210783387.
Use and Dose of Dengue Vaccine
Dengue fever vaccine is commonly intended for children and adults from ages 9-45 years. However, the benefits of providing dengue fever vaccines have proven to be more effective at ages 9-15.
The followings are instructions for use and dose of dengue vaccine:
- Dengue fever vaccine is usually given three times with the interval between injections from four to six months.
- The dose is given three times as much as 0.5 mL with an injection interval of six months.
- Dengue fever vaccine is given subcutaneously (under skin) in the upper arm of the deltoid region.
In addition, WHO recommends Dengvaxia dengue fever vaccine is given only to individuals who are known to have been infected with dengue before vaccinating. Consult with your doctor about the possibility of needing dengue fever vaccine. Moreover, you can do prevention by eradicating mosquito nests for example, draining the tub, sprinkling abate powder to kill mosquito larvae, closing water reservoirs, and spraying rooms in the house with insect repellent.